Comparison of lipid management in patients with coronary versus peripheral arterial disease

American Journal of Cardiology

Volumn 113, Issue 8, 2014, Pages 1320-1325

  Sharma, Suresh ^a   Thapa, Rashmi ^a   Jeevanantham, Vinodh ^a   Myers, Taylor ^a   Hu, Casper ^a   Brimacombe, Michael ^a   Vacek, James L ^a   Dawn, Buddhadeb ^a   Gupta, Kamal ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; EZETIMIBE PLUS SIMVASTATIN; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; NICOTINIC ACID; NICOTINIC ACID PLUS SIMVASTATIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL;

AGED; ARTICLE; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG USE; FEMALE; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBSERVATIONAL STUDY; PATIENT CARE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; UNITED STATES;

AGED; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KANSAS; LIPIDS; MALE; MORBIDITY; PERIPHERAL ARTERIAL DISEASE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84897437624     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.01.405     Document Type: Article

References (29)

1. W.C. Roberts The rule of 5 and the rule of 7 in lipid-lowering by statin drugs Am J Cardiol 80 1997 106 107
2. P. Jones, S. Kafonek, I. Laurora, and D. Hunninghake Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study) Am J Cardiol 81 1998 582 587
3. D.J. Maron, S. Fazio, and M.F. Linton Current perspectives on statins Circulation 101 2000 207 213
4. F.G. Fowkes, D. Rudan, I. Rudan, V. Aboyans, J.O. Denenberg, M.M. McDermott, P.E. Norman, U.K. Sampson, L.J. Williams, G.A. Mensah, and M.H. Criqui Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis Lancet 382 2013 1329 1340
5. E. Selvin, and T.P. Erlinger Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000 Circulation 110 2004 738 743
6. M.A. Allison, E. Ho, J.O. Denenberg, R.D. Langer, A.B. Newman, R.R. Fabsitz, and M.H. Criqui Ethnic-specific prevalence of peripheral arterial disease in the United States Am J Prev Med 32 2007 328 333
7. M.M. McDermott, P. Greenland, K. Liu, J.M. Guralnik, L. Celic, M.H. Criqui, C. Chan, G.J. Martin, J. Schneider, W.H. Pearce, L.M. Taylor, and E. Clark The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study Ann Intern Med 136 2002 873 883
8. M.M. McDermott, P. Greenland, K. Liu, J.M. Guralnik, M.H. Criqui, N.C. Dolan, C. Chan, L. Celic, W.H. Pearce, J.R. Schneider, L. Sharma, E. Clark, D. Gibson, and G.J. Martin Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment JAMA 286 2001 1599 1606
9. M.M. McDermott, K. Liu, P. Greenland, J.M. Guralnik, M.H. Criqui, C. Chan, W.H. Pearce, J.R. Schneider, L. Ferrucci, L. Celic, L.M. Taylor, E. Vonesh, G.J. Martin, and E. Clark Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms JAMA 292 2004 453 461
10. M.M. McDermott, J.M. Guralnik, L. Tian, L. Ferrucci, K. Liu, Y. Liao, and M.H. Criqui Baseline functional performance predicts the rate of mobility loss in persons with peripheral arterial disease J Am Coll Cardiol 50 2007 974 982
11. M.H. Criqui, R.D. Langer, A. Fronek, H.S. Feigelson, M.R. Klauber, T.J. McCann, and D. Browner Mortality over a period of 10 years in patients with peripheral arterial disease N Engl J Med 326 1992 381 386
12. M.T. Vogt, J.A. Cauley, A.B. Newman, L.H. Kuller, and S.B. Hulley Decreased ankle/arm blood pressure index and mortality in elderly women JAMA 270 1993 465 469
13. C. Diehm, S. Lange, H. Darius, D. Pittrow, B. von Stritzky, G. Tepohl, R.L. Haberl, J.R. Allenberg, B. Dasch, and H.J. Trampisch Association of low ankle brachial index with high mortality in primary care Eur Heart J 27 2006 1743 1749
14. F.G. Fowkes, G.D. Murray, I. Butcher, C.L. Heald, R.J. Lee, L.E. Chambless, A.R. Folsom, A.T. Hirsch, M. Dramaix, G. deBacker, J.C. Wautrecht, M. Kornitzer, A.B. Newman, M. Cushman, K. Sutton-Tyrrell, F.G. Fowkes, A.J. Lee, J.F. Price, R.B. d'Agostino, J.M. Murabito, P.E. Norman, K. Jamrozik, J.D. Curb, K.H. Masaki, B.L. Rodriguez, J.M. Dekker, L.M. Bouter, R.J. Heine, G. Nijpels, C.D. Stehouwer, L. Ferrucci, M.M. McDermott, H.E. Stoffers, J.D. Hooi, J.A. Knottnerus, M. Ogren, B. Hedblad, J.C. Witteman, M.M. Breteler, M.G. Hunink, A. Hofman, M.H. Criqui, R.D. Langer, A. Fronek, W.R. Hiatt, R. Hamman, H.E. Resnick, J. Guralnik, and M.M. McDermott Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis JAMA 300 2008 197 208
15. Heart Protection Study Collaborative G MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
16. R. Collins, J. Armitage, S. Parish, P. Sleight, R. Peto, and Heart Protection Study Collaborative G Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions Lancet 363 2004 757 767
17. P.P. Aung, H.G. Maxwell, R.G. Jepson, J.F. Price, and G.C. Leng Lipid-lowering for peripheral arterial disease of the lower limb Cochrane Database Syst Rev 2007 CD000123
18. Heart Protection Study Collaborative G Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions J Vasc Surg 45 2007 645 654 discussion 653-644
19. P.M. Ho, J.A. Spertus, F.A. Masoudi, K.J. Reid, E.D. Peterson, D.J. Magid, H.M. Krumholz, and J.S. Rumsfeld Impact of medication therapy discontinuation on mortality after myocardial infarction Arch Intern Med 166 2006 1842 1847
20. C.A. Jackevicius, P. Li, and J.V. Tu Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction Circulation 117 2008 1028 1036
21. S. Baroletti, and H. Dell'Orfano Medication adherence in cardiovascular disease Circulation 121 2010 1455 1458
22. S. Yusuf, S. Islam, C.K. Chow, S. Rangarajan, G. Dagenais, R. Diaz, R. Gupta, R. Kelishadi, R. Iqbal, A. Avezum, A. Kruger, R. Kutty, F. Lanas, L. Lisheng, L. Wei, P. Lopez-Jaramillo, A. Oguz, O. Rahman, H. Swidan, K. Yusoff, W. Zatonski, A. Rosengren, K.K. Teo, and Prospective Urban Rural Epidemiology Study I Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey Lancet 378 2011 1231 1243
23. W.R. Lewis, A.G. Ellrodt, E. Peterson, A.F. Hernandez, K.A. LaBresh, C.P. Cannon, W. Pan, and G.C. Fonarow Trends in the use of evidence-based treatments for coronary artery disease among women and the elderly: findings from the get with the guidelines quality-improvement program Circ Cardiovasc Qual Outcomes 2 2009 633 641
24. K.K. Birtcher, W. Pan, K.A. Labresh, C.P. Cannon, G.C. Fonarow, and G. Ellrodt Performance achievement award program for Get with the Guidelines-Coronary Artery Disease is associated with global and sustained improvement in cardiac care for patients hospitalized with an acute myocardial infarction Crit Path Cardiol 9 2010 103 112
25. Y. Xian, W. Pan, E.D. Peterson, P.A. Heidenreich, C.P. Cannon, A.F. Hernandez, B. Friedman, R.G. Holloway, G.C. Fonarow, and Committee GS, Hospitals Are quality improvements associated with the Get with the Guidelines-Coronary Artery Disease (GWTG-CAD) program sustained over time? A longitudinal comparison of GWTG-CAD hospitals versus non-GWTG-CAD hospitals Am Heart J 159 2010 207 214
26. M.M. McDermott, S. Mehta, H. Ahn, and P. Greenland Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease J Gen Intern Med 12 1997 209 215
27. A.T. Hirsch, M.H. Criqui, D. Treat-Jacobson, J.G. Regensteiner, M.A. Creager, J.W. Olin, S.H. Krook, D.B. Hunninghake, A.J. Comerota, M.E. Walsh, M.M. McDermott, and W.R. Hiatt Peripheral arterial disease detection, awareness, and treatment in primary care JAMA 286 2001 1317 1324
28. T.F. Rehring, B.G. Sandhoff, R.S. Stolcpart, J.A. Merenich, and H.W. Hollis Jr. Atherosclerotic risk factor control in patients with peripheral arterial disease J Vasc Surg 41 2005 816 822
29. N.J. Stone, J. Robinson, A.H. Lichtenstein, C.N. Merz, C.B. Blum, R.H. Eckel, A.C. Goldberg, D. Gordon, D. Levy, D.M. Lloyd-Jones, P. McBride, J.S. Schwartz, S.T. Shero, S.C. Smith Jr., K. Watson, and P.W. Wilson 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 2013 (Epub ahead of print)